Ken Research States United States AI in Medical Imaging Market to Reach USD 3.08 Billion by 2030

AI medical imaging is progressing from isolated diagnostic algorithms toward enterprise platforms that combine clinical triage, workflow orchestration, cloud deployment, governance, and recurring service revenue.

Delhi, India, July 27, 2026: Ken Research has released its strategic market analysis titled "United States AI in Medical Imaging Market Outlook to 2030: Size, Share, Growth and Trends," revealing that the market was valued at USD 548 million in 2024 and is projected to reach approximately USD 3,080.2 million by 2030.

The market is expected to expand at a CAGR of 33.4% from 2025 to 2030, accelerating from the historical CAGR of 26.8% recorded between 2019 and 2024. Growth is being driven by increasing imaging volumes, FDA-cleared radiology algorithms, hospital demand for faster clinical workflows, cloud-based deployment, enterprise software integration, and broader adoption of artificial intelligence in stroke, oncology, breast screening, emergency imaging, and diagnostic decision support.

The United States remains one of the world's most imaging-intensive healthcare systems, recording more than 360 combined CT, MRI, and PET examinations per 1,000 people in 2021. This high utilization creates a strong economic case for technologies that can prioritize urgent scans, reduce reporting delays, support radiologists, improve workflow consistency, and increase the productivity of hospital imaging departments.

United States AI in Medical Imaging Market at a Glance
2024 market value: USD 548 million
2030 forecast value: USD 3,080.2 million
Forecast CAGR: 33.4%
Historical CAGR: 26.8%
2024 active deployments: Approximately 3,850
2030 projected deployments: More than 21,500
Leading imaging segment: CT Scan AI Solutions
Fastest-growing application: Breast Screening AI
2024 cloud deployment share: 42%
Leading regional market: Western United States

The 86-page report contains 34 chapters, profiles 10 major companies, evaluates the industry across multiple segmentation dimensions, and incorporates findings validated through 290 expert interviews with radiology leaders, hospital procurement heads, imaging technology executives, PACS integration specialists, and AI product teams.

"The United States AI in Medical Imaging Market is shifting from algorithm experimentation to scaled enterprise adoption," said Namit Goel, Research Director at Ken Research. "Hospitals increasingly want integrated solutions that improve turnaround time, strengthen clinical prioritization, support governance, and operate across multiple departments and imaging modalities."

Download the free sample report:
https://www.kenresearch.com/sample-report/us-ai-in-medical-imaging-market?utm_source=OpenPR&utm_medium=Referral&utm_campaign=PR

From Standalone Algorithms to Enterprise AI Infrastructure

The first stage of medical imaging AI adoption was characterized by hospitals testing individual algorithms for narrow clinical applications. The next stage is being shaped by broader enterprise requirements.

Health systems are increasingly evaluating AI platforms according to how effectively they integrate with picture archiving and communication systems, radiology information systems, electronic health records, cybersecurity frameworks, and clinical governance processes.

This change is expanding the addressable revenue pool beyond algorithm licensing. Vendors can increasingly generate revenue through:

Multi-year platform subscriptions
Integration and implementation services
Model-governance support
Managed cloud deployment
Workflow orchestration
Cross-modality packages
Enterprise maintenance and support
Additional clinical modules
Multi-site expansion contracts

The number of active AI imaging deployments increased from approximately 1,180 in 2019 to 3,850 in 2024. Deployments are projected to exceed 21,500 by 2030, reflecting the transition from limited trials to wider hospital and radiology-network implementation.

Average revenue per deployment stood at approximately USD 142,300 in 2024. This relatively stable realized value indicates that market expansion is being supported by broader adoption rather than aggressive software price reduction.

CT Imaging Remains the Strongest Commercial Entry Point

CT Scan AI Solutions generated approximately USD 191 million in 2024, accounting for 34.9% of total market value.

CT remains commercially dominant because it is central to emergency medicine, stroke assessment, trauma care, chest imaging, abdominal imaging, and acute neurological workflows. These applications frequently require rapid interpretation, making the operational value of AI easier for hospitals to quantify.

Hospitals can assess the return on CT-focused AI through measurable outcomes such as:

Faster prioritization of critical scans
Reduced report turnaround time
Earlier identification of urgent findings
Improved patient routing
Lower workflow backlogs
More consistent escalation of acute cases
Better utilization of radiologist capacity

This measurable operational impact makes CT one of the most defensible entry points for independent AI vendors, imaging equipment manufacturers, and enterprise workflow platforms.

Breast Screening Becomes the Fastest-Growing Opportunity

Breast screening AI is expected to represent the fastest-growing major application pool, expanding at approximately 38% CAGR.

The opportunity is supported by high screening volumes, repeat examinations, image-comparison requirements, quality assurance needs, and the growing use of AI to assist lesion detection and reading prioritization.

Breast imaging AI can be commercialized through:

Per-site software licences
Per-reader workflow modules
OEM-integrated mammography systems
Subscription-based screening platforms
Quality-management tools
Detection and risk-assessment modules
Enterprise screening contracts

Unlike many isolated diagnostic applications, breast screening provides a recurring-use environment in which AI can support standardized reading, workload management, follow-up evaluation, and high-volume screening operations.

Acute Neurology Strengthens the Clinical ROI Case

Neurology is one of the leading application categories because stroke and other acute neurological conditions require rapid clinical decisions.

AI tools can assist with scan prioritization, suspected stroke detection, care-team notification, workflow coordination, and time-sensitive treatment pathways.

The commercial case is particularly strong where the technology is connected to measurable clinical and financial outcomes. The report notes that acute-care reimbursement precedents have supported payments of up to USD 1,040 per use for qualifying AI-enabled care pathways, demonstrating that hospitals may be willing to pay for solutions that can directly improve treatment timing.

These economics favor vendors capable of connecting algorithm performance with:

Treatment-time reduction
Emergency workflow improvement
Better care coordination
Reduced length of stay
Higher clinical throughput
Documented patient outcomes
Oncology Imaging Creates a Long-Term Demand Base

The United States reported approximately 1.85 million new cancer cases in 2022, creating a substantial addressable market for AI-supported detection, lesion measurement, follow-up quantification, image comparison, and treatment-response assessment.

Oncology imaging creates opportunities across CT, MRI, mammography, and other diagnostic modalities. AI can support radiologists by identifying suspicious findings, comparing studies over time, quantifying lesion changes, and helping organize increasingly complex imaging records.

The commercial opportunity is especially relevant for vendors developing tools that can operate across multiple cancer pathways rather than relying on a single indication.

Cloud Deployment Reshapes the Revenue Model

Cloud-based deployment accounted for approximately 42% of the market in 2024, compared with about 18% in 2019. Its share is expected to approach 77% by 2030.

Cloud adoption is being supported by health systems seeking faster implementation, centralized updates, lower incremental rollout costs, and easier expansion across multiple sites.

Cloud-enabled platforms also make it easier for vendors to:

Deploy new clinical modules
Manage model updates remotely
Monitor system performance
Standardize workflows across hospital networks
Introduce subscription revenue models
Support multiple AI algorithms from one interface
Provide centralized governance and auditability

On-premises deployment remains important because healthcare organizations continue to prioritize cybersecurity, data privacy, workflow control, and integration with legacy infrastructure. However, cloud-based architectures are expected to grow faster as enterprise buyers seek scalable orchestration layers.

Hospital Networks Create Scalable Commercial Opportunities

The American Hospital Association counted approximately 6,100 hospitals in the United States in 2024, including 3,567 community hospitals operating within larger health systems.

This concentration creates a strong enterprise sales opportunity. A vendor that secures approval within a large integrated delivery network can potentially expand from a flagship hospital into satellite hospitals, outpatient imaging centers, and affiliated radiology practices.

Multi-site hospital systems can reduce customer acquisition costs and increase contract value for vendors offering:

Standardized PACS integration
Centralized governance
Multi-site pricing
Cross-department deployment
Enterprise cybersecurity
Shared clinical performance reporting
Consistent implementation support

This structure is expected to favor companies with established enterprise relationships and the technical capacity to support complex healthcare organizations.

The Market Is Moving Toward Recurring Platform Revenue

The next major profit-pool shift is expected to occur between isolated algorithms and application-layer platforms.

Standalone algorithms typically generate licence revenue linked to one imaging modality or clinical use case. Enterprise platforms can capture a broader combination of:

Recurring subscriptions
Integration fees
Implementation revenue
Governance services
Managed support
Workflow tools
Data orchestration
Cross-selling of additional modules

This model can increase customer retention and lifetime account value because the platform becomes embedded in hospital workflows rather than operating as an optional diagnostic add-on.

Get the complete report here:
https://www.kenresearch.com/industry-reports/us-ai-in-medical-imaging-market?utm_source=OpenPR&utm_medium=Referral&utm_campaign=PR

Five Strategic Decisions Shaping Market Success
1. Should Companies Build Point Solutions or Enterprise Platforms?

Point solutions may offer faster development and a clearer clinical focus, but their commercial scale can be constrained by hospital reluctance to manage numerous vendors.

Enterprise platforms require more substantial integration, governance, cybersecurity, and support capabilities. However, they can generate larger contracts, stronger retention, and broader cross-selling opportunities.

Companies must determine whether they want to compete through specialized clinical performance or platform-level integration.

2. Which Clinical Applications Offer the Clearest ROI?

Stroke, emergency CT, breast screening, and oncology provide some of the strongest commercialization pathways because they combine high imaging volumes with measurable clinical or workflow outcomes.

AI applications with less direct reimbursement or limited imaging volumes may require longer evidence-generation and hospital procurement cycles.

3. How Should Vendors Approach Health-System Sales?

Hospital sales require more than algorithm accuracy. Buyers increasingly assess interoperability, cybersecurity, workflow fit, implementation timelines, regulatory documentation, model transparency, and post-deployment support.

Winning vendors will need to build relationships with radiology leaders, imaging CIOs, hospital procurement departments, compliance teams, and clinical governance committees.

4. What Deployment Model Should Be Prioritized?

Cloud deployment offers scalability, recurring revenue, and remote management. On-premises deployment provides greater local control and may remain necessary for organizations with strict data-security requirements.

A hybrid architecture may allow vendors to support a wider range of hospitals while accommodating differences in IT maturity and cybersecurity policy.

5. Where Should Investment Be Directed?

Priority investment areas may include:

FDA regulatory capabilities
PACS and EHR interoperability
Clinical evidence generation
Enterprise cybersecurity
Cloud infrastructure
Workflow orchestration
Hospital implementation teams
Multi-modality AI packages
Post-market model monitoring
Reimbursement and health-economic analysis
Commercial Barriers Remain Significant

Despite rapid growth, the United States AI in Medical Imaging Market faces several commercialization challenges.

Reimbursement Is Still Selective

Many AI applications do not receive direct reimbursement. Vendors must often prove value through improved productivity, lower operating costs, higher throughput, reduced reporting delays, or improved clinical outcomes.

This creates a disadvantage for narrow algorithms that cannot demonstrate enterprise-level benefits.

Evidence Requirements Are Increasing

Hospitals increasingly require robust clinical validation, transparency, intended-use documentation, data provenance, performance monitoring, and regulatory clarity.

These requirements can increase development and selling costs, particularly for smaller companies without dedicated regulatory, clinical, and implementation teams.

Workflow Environments Remain Fragmented

Hospitals may operate imaging equipment from multiple manufacturers alongside different PACS, radiology information systems, and electronic health record platforms.

This fragmentation increases integration complexity and can delay implementation, especially in rural hospitals and smaller community facilities with limited informatics resources.

Cybersecurity and Governance Affect Procurement

Medical imaging AI platforms may process sensitive healthcare data and influence clinical workflows. Hospitals therefore require strong access controls, auditability, cybersecurity safeguards, and model-governance systems.

Multi-factor authentication is the leading authentication category because healthcare buyers prioritize compliance, traceability, and protection of clinical information.

Competitive Landscape: OEM Scale Meets Specialized AI Innovation

The market remains moderately fragmented, with global imaging manufacturers competing alongside specialized artificial intelligence companies.

Major companies identified in the report include:

Siemens Healthineers
GE HealthCare
Philips Healthcare
IBM Watson Health
Canon Medical Systems
Aidoc
Zebra Medical Vision
Arterys
Tempus
Qure.ai

The report identifies approximately 215 market participants in 2024 and notes that eight new entrants joined the market during the previous five years.

Large imaging equipment manufacturers benefit from installed-base access, existing hospital relationships, equipment integration, regulatory capabilities, and enterprise support infrastructure.

Specialized vendors compete through clinical focus, workflow impact, deployment speed, algorithm performance, and innovation in areas such as stroke, chest imaging, breast screening, and incidental findings.

The competitive assessment examines companies across:

Market penetration
Clinical validation depth
FDA clearance breadth
Product portfolio breadth
Enterprise integration capability
Cloud readiness
Workflow orchestration strength
Hospital partnerships
Revenue-model diversity
Regulatory compliance maturity
Regulation Is Becoming a Competitive Advantage

FDA clearance, healthcare interoperability, model transparency, and post-market governance are becoming increasingly important commercial differentiators.

Regulatory capability affects not only market access but also hospital confidence, sales-cycle duration, legal review, and procurement approval.

Vendors with mature regulatory and clinical evidence functions may be better positioned to support:

Multi-hospital implementation
New clinical applications
Product updates
Enterprise governance
Model-performance monitoring
Long-term hospital contracts

Healthcare buyers are also paying closer attention to how models are updated, how performance is monitored, and how AI recommendations are presented to clinicians.

Strategic Value for Decision-Makers

"What distinguishes this report is its focus on the economics of enterprise adoption," noted Harsh Saxena, Principal at Ken Research. "It examines not only market growth, but also which clinical use cases offer measurable returns, how hospital buying decisions are evolving, and where recurring platform revenue is likely to emerge."

The report provides executives, investors, hospitals, imaging companies, software vendors, and financial institutions with:

Historical market sizing from 2019 to 2024
Market forecasts from 2025 to 2030
Revenue and deployment projections
Historical and forecast CAGR analysis
Average revenue per deployment
Cloud and on-premises deployment analysis
Imaging modality segmentation
Clinical application segmentation
Authentication-type assessment
Regional market analysis
Competitive benchmarking
FDA and interoperability analysis
Hospital procurement insights
Reimbursement and commercialization assessment
Market-entry strategy
White-space analysis
Pricing and positioning recommendations
Partner identification
Capital and implementation planning
Profitability and risk assessment
Execution roadmap

The research methodology combines FDA radiology AI clearance mapping, hospital infrastructure assessment, breast-screening policy analysis, OEM portfolio evaluation, desk research, and primary interviews.

The results were validated through 290 expert interviews, with market revenue, active deployments, vendor performance, hospital purchasing behavior, and forecast assumptions triangulated across buyers and suppliers.

Book a discovery call with our experts:
https://www.kenresearch.com/book-a-discovery-call?utm_source=OpenPR&utm_medium=Referral&utm_campaign=PR

"As hospital systems move beyond AI pilots, commercial success will depend on workflow integration, clinical validation, enterprise scalability, and measurable operational value," added Harsh Saxena. "The companies that can combine these capabilities with recurring platform economics will be best positioned to lead the market through 2030."

Industry executives seeking access to the complete analysis can contact Ken Research directly or visit:

https://www.kenresearch.com/industry-reports/us-ai-in-medical-imaging-market?utm_source=OpenPR&utm_medium=Referral&utm_campaign=PR

Related Reports

Asia Pacific Medical Imaging Market Outlook to 2030
https://www.kenresearch.com/industry-reports/asia-pacific-medical-imaging-market?utm_source=OpenPR&utm_medium=Referral&utm_campaign=PR

Saudi Arabia Medical Imaging Market Outlook to 2030
https://www.kenresearch.com/industry-reports/saudi-arabia-medical-imaging-market?utm_source=OpenPR&utm_medium=Referral&utm_campaign=PR

Indonesia Medical Imaging Market Outlook to 2030
https://www.kenresearch.com/industry-reports/indonesia-medical-imaging-market?utm_source=OpenPR&utm_medium=Referral&utm_campaign=PR

Media Contact

Ken Research Pvt. Ltd.
Ankur Gupta
Sales and Marketing
Phone: +91-9015378249
Email: ankur.gupta@kenresearch.com

Unit 14, Tower B3, Spaze I-Tech Business Park,
Sohna Road, Sector 49, Gurgaon,
Haryana 122001, India.

Ken Research delivers strategic market intelligence that drives confident decision-making for industry leaders. With specialized expertise in high-growth markets across emerging economies, the firm provides data-driven insights that translate into competitive advantage for global organizations and investors.

This release was published on openPR.